Medtronic Broadcasts Closing of €3.5 Billion Senior Bond Public Providing

DUBLIN, September 21, 2022 /PRNewswire/ — Medtronic plc (the “Firm”) (NYSE: MDT) in the present day introduced that its wholly owned subsidiary Medtronic World Holdings SCA (“Medtronic Luxco”) has closed a registered public providing (the “Providing”) €500,000,000 of two.625% Senior Notes maturing in 2025, €1,000,000,000 of three.000% Senior Notes maturing in 2028, €1,000,000,000 of three.125% due 2031 and €1,000,000,000 3.375% Senior Notes due 2034 (collectively, the “Notes”). All obligations of Medtronic Luxco beneath the Notes are totally and unconditionally assured by the Firm and Medtronic, Inc., an oblique wholly-owned subsidiary of Medtronic Luxco, on a senior unsecured foundation.

The online proceeds of the Providing are roughly €3.47 billion, after deducting underwriting reductions and charges and estimated bills associated to the Providing payable by Medtronic Luxco. The online proceeds of the Providing are anticipated for use to redeem at maturity the 0.00% Senior Notes due 2022, the 0.375% Senior Notes due 2023 and the 0.00% Senior Notes due 2023. 00% due 2023 of Medtronic Luxco and for common company functions. Though Medtronic Luxco could elect at a later date to redeem, redeem or repurchase such Notes previous to maturity, it at the moment has no intention of redeeming, redeeming or repurchasing such Notes previous to maturity.

Data regarding the Supply
Barclays Financial institution PLC, BofA Securities Europe SA, Citigroup World Markets Restricted and HSBC Continental Europe have been the joint bookrunners of the Supply and Academy Securities, Inc., R. Seelaus & Co., LLC, Samuel A. Ramirez & Firm, Inc. and Siebert Williams Rod & Co., LLC have been the co-managers of the Providing. The providing has been made by the use of a prospectus and a prospectus complement, copies of which can be obtained freed from cost by visiting EDGAR on the web site of america Securities and Trade Fee at www.sec.gov. Alternatively, copies of the prospectus and prospectus complement for the Providing could also be obtained by contacting Barclays Financial institution PLC, toll free at +1-888-603-5847, BofA Securities Europe SA, at +33(0) 1 8770 0000 , Citigroup World Markets Restricted toll free at +1-800-831-9146 and HSBC Continental Europe at +1-866-811-8049.

About Medtronic
Daring considering. Bolder actions. We’re Medtronic. Medtronic plc, headquartered in Dublin, Eire, is the worldwide well being know-how chief boldly tackling the hardest well being challenges dealing with humanity by researching and discovering options. Our mission – to alleviate ache, restore well being and prolong life – unites a world group of greater than 95,000 passionate individuals in 150 nations. Our applied sciences and therapies tackle 70 well being circumstances and embrace cardiac gadgets, surgical robotics, insulin pumps, surgical instruments, affected person monitoring techniques, and extra. With our numerous data, insatiable curiosity, and want to assist everybody in want, we ship modern applied sciences that remodel two individuals’s lives each second, each hour, day-after-day. Anticipate extra from us as we ship insight-driven care, experiences that put individuals first, and higher outcomes for our world. In every thing we do, we design the extraordinary.

Ahead-looking statements
This press launch could also be deemed to include forward-looking statements relating to future occasions which might be topic to the secure harbor created beneath the Personal Securities Litigation Reform Act of 1995 and different secure harbors beneath the Securities Act and the Securities Trade Act of 1934. All statements apart from statements of historic info are statements that could possibly be thought-about forward-looking statements, together with, however not restricted to, statements regarding the meant use of the product of the Supply.

You must pay explicit consideration to the fabric danger elements and cautionary statements referenced within the “Danger Components” part of the prospectus regarding the above talked about providing, in addition to the chance elements and cautionary statements described in Medtronic plc’s filings with the SEC, together with the chance elements contained in Medtronic plc’s most up-to-date Annual Report on Type 10-Ok. Medtronic plc doesn’t undertake to replace its forward-looking statements.

SOURCEMedtronic plc